Multiple myeloma SOHO 2026 Archives - SOHO Insider

Skip to content

Blinatumomab effectively replaces conventional chemotherapy cycles for pediatric patients with B-ALL
Iberdomide combination improves MRD–negative complete response rates versus DVd in relapsed or refractory multiple myeloma
Experts offer advice on treating patients with belantamab mafodotin-based combinations in myeloma
Incorporating blinatumomab into frontline therapy for high-risk B-ALL improves MRD, survival outcomes
Saad Usmani, MD, discusses iberdomide approval in relapsed multiple myeloma

Insider Reader Survey

Join SOHO

Follow Us :

Insider Podcast
Society Updates/Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Saad Usmani, MD, discusses iberdomide approval in relapsed multiple myeloma

Cellular Therapy

Saad Usmani, MD, discusses iberdomide approval in relapsed multiple myeloma

Leukemia

Saad Usmani, MD, discusses iberdomide approval in relapsed multiple myeloma

Lymphoma

Saad Usmani, MD, discusses iberdomide approval in relapsed multiple myeloma

Multiple Myeloma

Saad Usmani, MD, discusses iberdomide approval in relapsed multiple myeloma

Myelodysplastic Syndromes

Saad Usmani, MD, discusses iberdomide approval in relapsed multiple myeloma

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

October 11, 2026

Insider Podcast
Society Updates/Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Meetings / Conferences SOHO 2026 Multiple Myeloma News

Multiple Myeloma News

News and highlights on multiple myeloma from the 14th Annual Meeting of SOHO in Houston.

Multiple Myeloma News SOHO 2026 Trending now Meetings / Conferences

Saad Usmani, MD, discusses iberdomide approval in relapsed multiple myeloma

by Leah Sherwood
October 7, 2026
0 Comments

Multiple Myeloma News SOHO 2026 Trending now Meetings / Conferences

Prophylactic tocilizumab can reduce CRS severity during bispecific step-up dosing

by Kerri Fitzgerald
September 13, 2026
0 Comments

Chimeric antigen therapy

Multiple Myeloma News SOHO 2026 Trending now Meetings / Conferences

Study supports bispecifics as effective post-CAR-T strategy in relapsed/refractory MM

by Kerri Fitzgerald
September 13, 2026
0 Comments

pink back ground , multiple myeloma spelled out in wooden blocks

Multiple Myeloma News SOHO 2026 Meetings / Conferences

BCMA-directed bispecifics show meaningful efficacy in relapsed/refractory MM, but infection remains a risk

by Kerri Fitzgerald
September 13, 2026
0 Comments

Multiple Myeloma. Multiple Myeloma disease blood test inmedical laboratory

Multiple Myeloma News SOHO 2026 Meetings / Conferences

Oral cryotherapy reduces mucositis after high-dose melphalan before ASCT

by Patrick Daly
September 10, 2026
0 Comments

daratumumab

Multiple Myeloma News SOHO 2026 Meetings / Conferences

Anselamimab offers significant reduction in all-cause mortality and cardiovascular hospitalization risk for kappa AL amyloidosis

by Patrick Daly
September 9, 2026
0 Comments

pink back ground , multiple myeloma spelled out in wooden blocks

Multiple Myeloma News SOHO 2026 Meetings / Conferences

Arlo-cel, an anti-GPRC5D CAR T-cell, achieves deep and durable responses for patients with relapsed or refractory multiple myeloma in phase 1 trial

by Patrick Daly
September 9, 2026
0 Comments

Multiple Myeloma News SOHO 2026 Trending now Meetings / Conferences

COVID-19 era associated with measurable excess mortality in patients with MM

by Kerri Fitzgerald
September 9, 2026
0 Comments

Multiple Myeloma News SOHO 2026 Meetings / Conferences

Study shows increase in pneumonia-related hospitalizations and costs in patients with MM

by Kerri Fitzgerald
September 9, 2026
0 Comments

Patient in a clinical setting completing a digital health-related quality of life (PRO) survey on a tablet.

Multiple Myeloma News SOHO 2026 Trending now Meetings / Conferences

Inpatient administration of bispecific antibody step-up dosing associated with financial burden

by Kerri Fitzgerald
September 9, 2026
0 Comments

1
2

Top Categories

Cellular Therapy

81

Leukemia

140

Lymphoma

142

Multiple Myeloma

122

Myelodysplastic Syndromes

51

Myeloproliferative Neoplasms

40

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Inpatient administration of bispecific antibody step-up dosing associated with financial burden

Cellular Therapy

Inpatient administration of bispecific antibody step-up dosing associated with financial burden

Leukemia

Inpatient administration of bispecific antibody step-up dosing associated with financial burden

Lymphoma

Inpatient administration of bispecific antibody step-up dosing associated with financial burden

Multiple Myeloma

Inpatient administration of bispecific antibody step-up dosing associated with financial burden

Myelodysplastic Syndromes

Inpatient administration of bispecific antibody step-up dosing associated with financial burden

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Mother holding child hand with saline IV solution in hospital

Blinatumomab effectively replaces conventional chemotherapy cycles for pediatric patients with B-ALL

Sagar Lonial

Iberdomide combination improves MRD–negative complete response rates versus DVd in relapsed or refractory multiple myeloma

Experts offer advice on treating patients with belantamab mafodotin-based combinations in myeloma

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.